Wilson Sonsini Goodrich & Rosati advised Novo Holdings A/S and Vida Ventures on the transaction.Avalyn Pharma Inc. announced the closing of an oversubscribed $175 million Series…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Leila Ahmed
…
This content is for Standard 1 Year members only. LoginJoin Now